Pardes Biosciences (PRDS) Short Interest Ratio & Short Volume

Short interest is the volume of Pardes Biosciences shares that have been sold short but have not yet been closed out or covered. As of August 15th, traders have sold 874,400 shares of PRDS short. 2.22% of Pardes Biosciences' shares are currently sold short. Learn More on Pardes Biosciences' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PRDS shares currently have a short interest ratio of 2.0. Learn More on Pardes Biosciences's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.22% of Pardes Biosciences' floating shares are currently sold short.

Pardes Biosciences saw a decline in short interest in August. As of August 15th, there was short interest totaling 874,400 shares, a decline of 4.9% from the previous total of 919,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Pardes Biosciences currently has issued a total of 62,012,000 shares. Some of Pardes Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Pardes Biosciences currently has a public float of 39,460,000 shares.

2.22% of Pardes Biosciences' shares are currently sold short. Here is how the short interest of companies compare to Pardes Biosciences: Kinnate Biopharma Inc. (2.01%), Accretion Acquisition Corp. (0.01%), Theseus Pharmaceuticals, Inc. (2.63%), Moolec Science SA (0.14%), Fortress Biotech, Inc. (14.08%), LianBio (0.36%), Live Oak Crestview Climate Acquisition Corp. (0.01%), Innovid Corp. (0.38%), Harpoon Therapeutics, Inc. (4.31%), Computer Programs and Systems, Inc. (3.32%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.78 billion), Occidental Petroleum Co. ($3.04 billion), Royal Caribbean Cruises Ltd. ($2.10 billion), Celsius Holdings, Inc. ($1.98 billion), Coinbase Global, Inc. ($1.97 billion), T. Rowe Price Group, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.83 billion), Tractor Supply ($1.82 billion), Moderna, Inc. ($1.66 billion), and CarMax, Inc. ($1.49 billion). View all of the most shorted stocks.

Short selling PRDS is an investing strategy that aims to generate trading profit from Pardes Biosciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Pardes Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PRDS, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PRDS, twice per month. The most recent reporting period available is August, 15 2023.